Lehdistötiedote

Learning 2 Sleep obtains ORCHA certification

After evaluation by the British certification company ORCHA, Learning 2 Sleep has become the first company in Sweden to receive their quality certification for mobile applications at level 4, which is currently of great importance in the British market and will also have a positive effect in the Nordic region in the future.

Since 2015, ORCHA has been evaluating mobile applications in the UK on behalf of the British health authority (NHS). This has formed the basis for the British "app library," which controls which mobile applications can be prescribed by healthcare and therefore qualify for public reimbursement.
Last fall, ORCHA was commissioned by the Nordic countries to conduct a similar evaluation of apps in the Nordic region to start creating a Nordic app library - NordDEC. Learning 2 Sleep is one of the first companies to be evaluated according to this standard, and as a first step, the company's sleep treatment has received the British certification, which means that L2S is now available in the British app library. The next step is to begin work on the NordDEC certification.
"We are incredibly happy that we have now taken the first step towards a Nordic certification. A quality control of the mobile applications within the healthcare area is needed, and the UK has been a pioneering country in this regard. Given our very strong results in the research study conducted by Karolinska on our treatment, the certification is further proof that our treatment is of the highest quality. Now we look forward to the next step in the process, the specific Nordic certification," says Lina Johansson, CEO of Learning 2 Sleep.

About ORCHA

ORCHA (The Organisation for the Review of Care and Health Apps) provides the basic infrastructure to overcome the obstacles in healthcare regarding digital technology and to introduce digital health in a secure manner. The organization's technology establishes quality assurance procedures that have long been followed by other areas of medical practice.

https://orchahealth.com

About Us

Learning to Sleep is a digital care provider specializing in the treatment of chronic sleep disorders. The treatment is a combination of a structured treatment program in a mobile application and weekly digital meetings with a psychologist. The company's treatment is based on the latest research in the field and is very successful - over 90 percent of the patients treated receive improved sleep. Sweden is the company's main market and the treatment is reimbuserd by public health care.
For more information see www.learningtosleep.co.uk
The company's Certified Adviser is Eminova Fondkomission AB | +468 684 211 10 | adviser@eminova.se

Statements about the future

This press release contains forward-looking statements that refer to the Company's intentions, assessments or expectations regarding the Company's future results, financial position, liquidity, development, prospects, expected growth, strategies and opportunities as well as the markets in which the Company operates. Forward-looking statements are statements that do not relate to historical facts and can be identified by the inclusion of expressions such as "believes", "expects", "anticipates", "intends", "estimates", "will", "may", "assumes", "should" "could" and, in each case, negations thereof, or similar expressions. The forward-looking statements in this press release are based on various assumptions, which in several cases are based on additional assumptions. Although the Company believes that the assumptions reflected in these forward-looking statements are reasonable, there can be no assurance that they will occur or that they are accurate. As these assumptions are based on assumptions or estimates and are subject to risks and uncertainties, the actual result or outcome may, for many different reasons, differ materially from what appears in the forward-looking statements. Such risks, uncertainties, contingencies and other material factors may cause actual events to differ materially from the expectations expressed or implied in this press release through the forward-looking statements. The Company does not warrant that the assumptions underlying the forward-looking statements in this press release are correct and any reader of the press release should not place undue reliance on the forward-looking statements in this press release. The information, opinions and forward-looking statements expressed or implied herein are provided only as of the date of this press release and are subject to change. Neither the Company nor anyone else undertakes to revise, update, confirm or publicly announce any revision of any forward-looking statement to reflect events occurring or circumstances occurring with respect to the contents of this press release, except as required by law or Nasdaq First North Growth Markets' regulations for issuers.